Category Archives: Presentation

Findings or research presented at a conference that have not necessarily been peer-reviewed

Thousands of melanoma patients in Europe have no access to new life saving drugs

Unacceptable inequalities in the availability and accessibility of new and effective cancer medications across Europe. Over 5000 patients with metastatic melanoma in Europe are denied access to new, life-saving drugs every year, according to a survey presented at the ESMO … Continue reading

Posted in Presentation | Tagged , | Leave a comment

Chemotherapy and exercise: The right dose of workout helps side effects

Researchers at the University of Rochester Wilmot Cancer Institute discovered something simple and inexpensive to reduce neuropathy in hands and feet due to chemotherapy – exercise. The study, involving more than 300 cancer patients, is to be presented this weekend … Continue reading

Posted in Presentation | Tagged , , | Leave a comment

Counseling patients at risk for cancer over the phone reduces costs and access burdens

Patients who receive results of genetic tests over the phone do not experience increased anxiety or depression. Delivering genetic test results to patients at risk for cancer-causing genetic mutations over the phone helps to ease cost and transportation burdens and, … Continue reading

Posted in Presentation | Tagged , , | Leave a comment

Hispanic and black young adult cancer patients more likely to die of their disease

Hispanic white and non-Hispanic black cancer patients between ages 15 and 29 may be more likely than same-aged white patients to die of their disease, according to a University of Colorado Cancer Center study presented at the American Society for … Continue reading

Posted in Presentation | Tagged , | Leave a comment

Chemoradiation may increase survival for a subset of elderly head and neck cancer patients

The addition of chemotherapy (CT) to radiation therapy (RT) improves survival rates among a subset of elderly head and neck cancer patients, specifically those ages 71 to 79 with low comorbidity scores and advanced disease stage, according to University of … Continue reading

Posted in Presentation | Tagged , , , | Leave a comment

Why does tamoxifen work better in some women?

The anti-hormone therapy tamoxifen can reduce breast cancer recurrence by about half in women with hormone-sensitive breast cancer. But it works better in some women than others. Researchers are not sure why. “We do know that some tumors are inherently … Continue reading

Posted in Presentation | Tagged | Leave a comment

Anti-androgen therapy improves survival for men with cancer recurrence after prostatectomy

Men with prostate cancer who haveĀ prostate-specific antigenĀ recurrence following radical prostatectomy have improved survival with radiotherapy and a long-term course of anti androgen therapy. It is well established that a rising serum prostate-specific antigen (PSA) level is an indication of cancer … Continue reading

Posted in Presentation | Tagged , , , | Leave a comment